Top Midday Decliners

MT Newswires Live04-11 01:08

One and One Green Technologies (YDDL) said Friday it signed an agreement with two institutional investors to sell about 1.7 million units in a follow-on offering of its securities at $7.50 per unit, for expected gross proceeds of about $13 million.

Shares slid 62%, with intraday trading volume at over 992,000, versus a daily average of roughly 196,000.

Angel Studios (ANGX) said Friday that it priced an underwritten public offering of 14.3 million shares of Class A common stock at $2.10 per share, raising $30 million in expected gross proceeds.

Shares sank 26% following an increase in intraday trading volume to over 8.62 million from a daily average of about 762,000.

Replimune Group's (REPL) biologics license application for vusolimogene oderparepvec was rejected by the US Food and Drug Administration, the regulator said in a complete response letter on Friday.

Shares slumped 19% as intraday trading volume soared to more than 2.94 million from a daily average of about 1.75 million.

Price: 5.20, Change: -8.71, Percent Change: -62.62

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2626114148?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-11 01:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2626114148","market":"hk","top_or_hot":-1,"title":"Top Midday Decliners","media":"MT Newswires Live","content":"<html><body><p> One and One Green Technologies (YDDL) said Friday it signed an agreement with two institutional investors to sell about 1.7 million units in a follow-on offering of its securities at $7.50 per unit, for expected gross proceeds of about $13 million.</p><p>Shares slid 62%, with intraday trading volume at over 992,000, versus a daily average of roughly 196,000.</p><p><a href=\"https://laohu8.com/S/ANGX\">Angel Studios</a> (ANGX) said Friday that it priced an underwritten public offering of 14.3 million shares of Class A common stock at $2.10 per share, raising $30 million in expected gross proceeds.</p><p>Shares sank 26% following an increase in intraday trading volume to over 8.62 million from a daily average of about 762,000.</p><p>Replimune Group's (REPL) biologics license application for vusolimogene oderparepvec was rejected by the US Food and Drug Administration, the regulator said in a complete response letter on Friday.</p><p>Shares slumped 19% as intraday trading volume soared to more than 2.94 million from a daily average of about 1.75 million.</p><p>Price: 5.20, Change: -8.71, Percent Change: -62.62</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Decliners</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Decliners\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-04-11 01:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> One and One Green Technologies (YDDL) said Friday it signed an agreement with two institutional investors to sell about 1.7 million units in a follow-on offering of its securities at $7.50 per unit, for expected gross proceeds of about $13 million.</p><p>Shares slid 62%, with intraday trading volume at over 992,000, versus a daily average of roughly 196,000.</p><p><a href=\"https://laohu8.com/S/ANGX\">Angel Studios</a> (ANGX) said Friday that it priced an underwritten public offering of 14.3 million shares of Class A common stock at $2.10 per share, raising $30 million in expected gross proceeds.</p><p>Shares sank 26% following an increase in intraday trading volume to over 8.62 million from a daily average of about 762,000.</p><p>Replimune Group's (REPL) biologics license application for vusolimogene oderparepvec was rejected by the US Food and Drug Administration, the regulator said in a complete response letter on Friday.</p><p>Shares slumped 19% as intraday trading volume soared to more than 2.94 million from a daily average of about 1.75 million.</p><p>Price: 5.20, Change: -8.71, Percent Change: -62.62</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2626114148","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2626114148","pubTimestamp":1775840913,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"One and One Green Technologies  said Friday it signed an agreement with two institutional investors to sell about 1.7 million units in a follow-on offering of its securities at $7.50 per unit, for expected gross proceeds of about $13 million.Shares slid 62%, with intraday trading volume at over 992,000, versus a daily average of roughly 196,000.Angel Studios  said Friday that it priced an underwritten public offering of 14.3 million shares of Class A common stock at $2.10 per share, raising $30 million in expected gross proceeds.Shares sank 26% following an increase in intraday trading volume to over 8.62 million from a daily average of about 762,000.Replimune Group's  biologics license application for vusolimogene oderparepvec was rejected by the US Food and Drug Administration, the regulator said in a complete response letter on Friday.Shares slumped 19% as intraday trading volume soared to more than 2.94 million from a daily average of about 1.75 million.Price: 5.20, Change: -8.71, ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","ANGX":"Angel Studios","YDDL":"One and one Green","REPL":"Replimune Group Inc.","BK4108":"电影和娱乐","BK4168":"多种金属与采矿"},"translate_title":"午盘跌幅最大的股票","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"REPL":1,"YDDL":1,"ANGX":1},"content_text":"One and One Green Technologies (YDDL) said Friday it signed an agreement with two institutional investors to sell about 1.7 million units in a follow-on offering of its securities at $7.50 per unit, for expected gross proceeds of about $13 million.Shares slid 62%, with intraday trading volume at over 992,000, versus a daily average of roughly 196,000.Angel Studios (ANGX) said Friday that it priced an underwritten public offering of 14.3 million shares of Class A common stock at $2.10 per share, raising $30 million in expected gross proceeds.Shares sank 26% following an increase in intraday trading volume to over 8.62 million from a daily average of about 762,000.Replimune Group's (REPL) biologics license application for vusolimogene oderparepvec was rejected by the US Food and Drug Administration, the regulator said in a complete response letter on Friday.Shares slumped 19% as intraday trading volume soared to more than 2.94 million from a daily average of about 1.75 million.Price: 5.20, Change: -8.71, Percent Change: -62.62","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2626114148","isCrawlerRequest":true}